TS
At a glance
Registered since
2024
Senate LDA system
Clients
56
last 3 years
Filings
200
7 agencies contacted
Activity
filings by quarter
Works on
Background
Government experience
Advisor to the Assistant Secretary for Preparedness & Response
HHS; Advisor to the Assistant Secretary of Legislation, HHS; Health Care Policy Fellow, Representative Michael Burgess
Disclosed on LD-2 filings
Career
TS
Specific issues
Discussions concerning federal funding related to the Centers for Disease Control and Prevention.
Discussions concerning the FY 2024 appropriations bills; provisions related to FDA regulation of tobacco.
Discussions related to implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act. Discussions related to tobacco harm reduction. Discussions related to enforcement of illicit tobacco products, including importation of counterfeit products. Discussions related to user fees for tobacco and electronic nicotine delivery system products. Discussions related to efforts to prevent youth access to tobacco products.
Drug Pricing and Access. Pharmaceutical Supply Chain. Pharmacy Benefit Managers.
Part D changes. Prescription drug payment reform. 340B issues. Onshoring. HELP Copays Act. General Medicare and Medicaid Issues.
340B issues. Antimicrobial resistance. Supply Chain. Vaccine issues. Food and Drug Administration issues.
Clients
Filing history
MERCK & CO., INC.
ADULT VACCINE ACCESS COALITION
ASTELLAS PHARMA US, INC.
AMERICAN POLICY VENTURES ACTION
PMI US CORPORATE SERVICES INC.
EMD SERONO INC.
AMGEN INC.
ILLUMINA, INC.
ALEXION PHARMACEUTICALS, INC.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
MCKESSON CORPORATION
GENENTECH, INC.